[go: up one dir, main page]

US4303657A - Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof - Google Patents

Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof Download PDF

Info

Publication number
US4303657A
US4303657A US06/040,836 US4083679A US4303657A US 4303657 A US4303657 A US 4303657A US 4083679 A US4083679 A US 4083679A US 4303657 A US4303657 A US 4303657A
Authority
US
United States
Prior art keywords
compounds
hydrogen
carbon atoms
feed
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/040,836
Inventor
Vernon V. Young
Robert D. Williams
Richard E. Ivy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Minerals and Chemical Corp
Original Assignee
International Minerals and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Minerals and Chemical Corp filed Critical International Minerals and Chemical Corp
Priority to US06/040,836 priority Critical patent/US4303657A/en
Application granted granted Critical
Publication of US4303657A publication Critical patent/US4303657A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms

Definitions

  • This invention relates to substituted quinoxaline-1,4-dioxides.
  • this invention relates to a method of promoting the growth of animals.
  • a growth stimulant is a compound which elicits a response of an animal toward its optimum genetic potential from a depression in growth rate and feed efficiency caused by intestinal bacterial flora, stress and subclinical diseases. Some compounds also act to improve feed efficiency, i.e. they permit the animal to gain more weight per unit weight of food than would occur without the compound. Such compounds are highly advantageous in raising animals for food.
  • Antibiotics such as penicillin, bacitracin and tetracyclines have been widely used for this purpose. Antibiotics have several disadvantages, however. There is the possibility that resistant strains of pathogenic organisms may develop. Also, these antibiotics are expensive to use. Accordingly, there is a need for other agents to stimulate the growth of animals.
  • nitrohydroxyalkyl-substituted quinoxaline-1,4-dioxides of this invention are represented by the formula ##STR2## where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms, or R and R' taken together can be an alkylene group of 5 carbon atoms thereby forming a cyclohexyl moiety. It is also an embodiment of this invention to provide alkanoic acid esters of the hydroxy compounds.
  • esters can be readily esterified, e.g. by reaction with an acid anhydride or acid chloride, and the esters also have the properties of improving growth and increasing the feed efficiency.
  • nitrohydroxy compounds of this invention are readily prepared by reacting a nitroalkane of from 1 to 6 carbon atoms with 2-formylquinoxaline-1,4-dioxide hydrate in about a 1:1 mole ratio. It is also an embodiment of this invention to use a nitroalkanoic acid ester or a nitroalkanol in place of the nitroalkane.
  • the nitroalkanes useful in the practice of this invention include but are not limited to nitromethane, nitroethane, 1-nitropropane, 2-nitropropane, 1-nitrobutane, 2-nitrobutane and nitrocyclohexane.
  • a lower alkyl alcohol e.g. of from 1-4 carbon atoms, preferably methanol
  • the formyl quinoxaline dioxide hydrate and alkaline agent are preferably heated to near reflux temperatures, then the nitroalkane is added with agitation and the heat source is removed. Agitation is continued until the mixture reaches room temperature, during which time a precipitate forms. It can be recovered by filtration, centrifugation or decantation, and preferably rinsed with a small amount of alkanol solvent, e.g. methanol. In some cases it may be preferable to recover the product by evaporation of the alkyl alcohol. When preferred, the product can be recrystallized from an alcohol solvent.
  • the formyl quinoxaline dioxide hydrate used in the practice of this invention can be prepared by the acid hydrolysis of 2-formylquinoxaline-1,4-dioxide dimethyl acetal, which is a known compound, described by M. J. Haddadin et al., British Pat. No. 1,305,138.
  • the hydrate compound is readily obtained by dissolving the dimethyl acetal compound in hot dilute hydrochloric acid (1 to 10%). The solution is allowed to cool and is then chilled whereupon the hydrate crystallizes. For a higher purity product, it may be desirable to treat the hot solution with activated charcoal and filtering before crystallization begins.
  • the alkaline conditions used in the production of the compounds of this invention can be provided by any suitable alkalinizing agent including sodium and potassium hydroxides or alkoxides and alkylamines, but generally strong amines such as tertiary alkylamines, e.g. triethylamine or tributylamine are preferred.
  • the amount can be varied considerably but it should be sufficient to provide, if in an aqueous system, a pH of from about 8 to 11. Generally this can be provided by an amount of, e.g., from 0.01 to 1.0%.
  • the alkanoic acid esters of the nitrohydroxy compounds of this invention are provided by conventional esterification reaction of the nitrohydroxy compound with an acid chloride or acid anhydride.
  • the acid chloride or anhydride is aliphatic of from 2 to 20 carbon atoms.
  • the formic ester can be prepared by reaction with formic acid.
  • the preferred esters are the acetic acid esters.
  • the method of this invention will be particularly suitable for animals raised for food such as fowl, ruminants, swine and rabbits.
  • animals raised for food such as fowl, ruminants, swine and rabbits.
  • the ruminants e.g. cattle, sheep and goats
  • the method is particularly of value for cattle, e.g. steers.
  • the method of administration of a compound of this invention is to incorporate it in the feed rations intended for the animal at a concentration of about 50-150 g/ton of feed, preferably about 100 g/ton.
  • the animals are permitted to feed at liberty throughout the growth period.
  • the compounds of this invention can be used with any of the known rations.
  • feed rations is intended to mean the food provided for the animals, and it is not intended that the invention be limited thereby.
  • the compound is thoroughly mixed with the feed ration so that it is uniformly dispersed throughout.
  • it is also contemplated that it could be sprinkled on the daily food supplies in the form of a powder or as pellets.
  • the invention be limited to any particular mode of administration.
  • Feed rations are formulated to provide the animal for which it is intended with the essential nutrients, minerals, vitamins, bulk, etc. Formulation of these rations are well within the skill of nutritionists.
  • Two groups of male two-day-old broiler-type chicks were placed into Petersime starter batteries and given feed and water ad libitum for the duration of each test. Each group was subdivided into six sub-groups with ten birds in each sub-group, thus providing sixty birds per group.
  • One group received the basal feed ration, as given in Table 1 and served as a control.
  • the other group receives the same ration, but in addition there was included P-2229 at a concentration of 100 g/ton.
  • the basal ration was a rye diet which alters the microflora of the gut in the bird which results in a growth depressant effect. When a growth stimulant or promotant is added to the diet, the effect on the birds performance will be more apparent than if a corn base diet was used.
  • test period was thirteen days. Individual live body weights and pen feed efficiencies were taken at 2 and 14 days of age. The data are given in Table 2. Growth promotion of P-2229 is indicated by the average percentage increase in weight over that of the control group, and feed efficiency is taken as the ratio of weight of feed consumed to weight gained and the increase of this ratio over the ratio exhibited by controls is taken as the increase of feed efficiency.
  • Example 2 The experiment of Example 1 was repeated in all essential details except that nitroethane, 1.5 g (0.02 mole) was substituted for methyl nitroacetate and it was recrystallized from ethanol. There was obtained 2-(1-hydroxy-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 206-208 with decomposition. It was designated P-2230 for convenience. It analyzed as follows:
  • Example 2 The experiment of Example 2 was repeated in all essential details except that nitromethane 1.0 g (0.016 mole) was substituted for nitroethane. There was obtained 2-(1-hydroxy-2-nitroethyl)-quinoxaline-1,4-dioxide, m.p. 202°-204° C., with decomposition. It was designated P-2231 for convenience. It analyzed as follows:
  • Example 2 The experiment of Example 2 was repeated in all essential details except that 1-nitropropane was substituted for nitroethane in an equimolar amount. There was obtained 2-(1-hydroxy-2-nitrobutyl)quinoxaline-1,4-dioxide, m.p. 197-199. It was designated P-2246 for convenience. It analyzed as follows:
  • Example 4 The experiment of Example 4 was repeated in all essential details except that 2-nitropropane was substituted for 1-nitropropane. There was obtained 2-(1-hydroxy-2-methyl-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 190-192. It was designated P-2265 for convenience. It analyzed as follows:
  • Example 2 The experiment of Example 2 was repeated in all essential details except that 2-nitro-1-butanol was substituted for nitroethane in equimolar amounts. There was obtained 2-(1-hydroxy-2-hydroxymethyl-2-nitrobutyl)quinoxaline-1,4-dioxide, a viscous liquid. It was designated P-2280 for convenience. It causes improved growth rate and improved efficiency when tested in feed rations. P-2280 is also useful in controlling the growth of certain bacteria and fungi as shown by the following minimum inhibitory concentrations (MIC):
  • MIC minimum inhibitory concentrations
  • Example 7 The experiment of Example 7 was repeated in all essential details except that the product of Example 2, P-2230, was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 186-190 with decomposition. It was designated P-2242 for convenience.
  • Example 7 The experiment of Example 7 was repeated in all essential details except that the product of Example 3, P-2231 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitroethyl)quinoxaline-1,4-dioxide, m.p. 201-204. It was designated P-2243 for convenience. It analyzed as follows:
  • Example 7 The experiment of Example 7 was repeated in all essential details except that P-2246 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitrobutyl)quinoxaline-1,4-dioxide, m.p. 156-158 with decomposition. It was designated P-2277 for convenience. It analyzed as follows:
  • P-2277 improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 7 The experiment of Example 7 was repeated in all essential details except that P-2265 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-methyl-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 183-185. It was designated P-2284 for convenience. P-2284 improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 7 The experiment of Example 7 is repeated in all essential details except that P-2280 is substituted for P-2229. There is obtained 2-(1-acetoxy-2-acetoxymethyl-2-nitrobutyl)quinoxaline-1,4-dioxide. The compound improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 2 The experiment of Example 2 is repeated in all essential details except that 1-nitrobutane is substituted for nitroethane in equimolar amounts. There is obtained 2-(1-hydroxy-2-nitropentyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 2 The experiment of Example 2 is repeated in all essential details except that 2-nitrobutane is substituted for nitroethane in equimolar amounts. There is obtained 2-(1-hydroxy-2-methyl-2-nitrobutyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 2 The experiments of Example 2 is repeated in all essential details except that nitrocyclohexane is substituted for nitroethane in equimolar amounts. There is obtained ⁇ -(1-nitrocyclohexyl)-2-quinoxalinemethanol-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 7 The experiment of Example 7 is repeated in all essential details except that the product of Example 13 is substituted for P-2229. There is obtained 2-(1-acetoxy-2-nitropentyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 7 The experiment of Example 7 is repeated in all essential details except that the product of Example 14 is substituted for P2229. There is obtained 2-(1-acetoxy-2-methyl-2-nitrobutyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
  • Example 7 The experiment of Example 7 is repeated in all essential details except that the product of Example 15 is substituted for P-2229 . There is obtained the acetic acid ester of the product of Example 15. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nitrohydroxyalkylquinoxaline-1,4-dioxides represented by the formula ##STR1## where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms or R and R' taken together can be alkylene of 5 carbon atoms and alkanoic acid esters thereof. The compounds are useful for promoting growth rate of animals and improving their feed efficiency.

Description

BACKGROUND OF THE INVENTION
This invention relates to substituted quinoxaline-1,4-dioxides. In a particular aspect this invention relates to a method of promoting the growth of animals.
In the business of raising animals for food, it is essential to feed the animals those rations and adjuncts thereto, such as growth promoter stimulants, that provide a rapid weight gain and a high conversion of feed to animal weight. Such compounds cause the animal to gain weight faster during the growth period, thus shortening the time required to bring the animal to market weight. A growth stimulant is a compound which elicits a response of an animal toward its optimum genetic potential from a depression in growth rate and feed efficiency caused by intestinal bacterial flora, stress and subclinical diseases. Some compounds also act to improve feed efficiency, i.e. they permit the animal to gain more weight per unit weight of food than would occur without the compound. Such compounds are highly advantageous in raising animals for food. Antibiotics such as penicillin, bacitracin and tetracyclines have been widely used for this purpose. Antibiotics have several disadvantages, however. There is the possibility that resistant strains of pathogenic organisms may develop. Also, these antibiotics are expensive to use. Accordingly, there is a need for other agents to stimulate the growth of animals.
SUMMARY OF THE INVENTION
It is an object of this invention to provide substituted quinoxaline dioxides.
It is another object of this invention to provide a method for promoting the growth of animals.
It is yet another object of this invention to provide a method for improving the feed efficiency of animals.
Still other objects of this invention will be apparent to those skilled in the art from the disclosure herein.
It is the discovery of this invention to provide nitrohydroxyalkyl-substituted quinoxaline-1,4-dioxides and their alkanoic acid esters and method of preparation. It is also an embodiment of this invention to provide a method of improving the growth rate of animals and increasing their feed efficiency.
DETAILED DISCUSSION
The nitrohydroxyalkyl-substituted quinoxaline-1,4-dioxides of this invention are represented by the formula ##STR2## where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms, or R and R' taken together can be an alkylene group of 5 carbon atoms thereby forming a cyclohexyl moiety. It is also an embodiment of this invention to provide alkanoic acid esters of the hydroxy compounds.
These compounds can be readily esterified, e.g. by reaction with an acid anhydride or acid chloride, and the esters also have the properties of improving growth and increasing the feed efficiency.
The nitrohydroxy compounds of this invention are readily prepared by reacting a nitroalkane of from 1 to 6 carbon atoms with 2-formylquinoxaline-1,4-dioxide hydrate in about a 1:1 mole ratio. It is also an embodiment of this invention to use a nitroalkanoic acid ester or a nitroalkanol in place of the nitroalkane. The nitroalkanes useful in the practice of this invention include but are not limited to nitromethane, nitroethane, 1-nitropropane, 2-nitropropane, 1-nitrobutane, 2-nitrobutane and nitrocyclohexane.
The reaction proceeds readily, especially at elevated temperatures and under alkaline conditions. Advantageously, a lower alkyl alcohol, e.g. of from 1-4 carbon atoms, preferably methanol, is used as a solvent. When a solvent is used, the formyl quinoxaline dioxide hydrate and alkaline agent are preferably heated to near reflux temperatures, then the nitroalkane is added with agitation and the heat source is removed. Agitation is continued until the mixture reaches room temperature, during which time a precipitate forms. It can be recovered by filtration, centrifugation or decantation, and preferably rinsed with a small amount of alkanol solvent, e.g. methanol. In some cases it may be preferable to recover the product by evaporation of the alkyl alcohol. When preferred, the product can be recrystallized from an alcohol solvent.
The formyl quinoxaline dioxide hydrate used in the practice of this invention can be prepared by the acid hydrolysis of 2-formylquinoxaline-1,4-dioxide dimethyl acetal, which is a known compound, described by M. J. Haddadin et al., British Pat. No. 1,305,138. The hydrate compound is readily obtained by dissolving the dimethyl acetal compound in hot dilute hydrochloric acid (1 to 10%). The solution is allowed to cool and is then chilled whereupon the hydrate crystallizes. For a higher purity product, it may be desirable to treat the hot solution with activated charcoal and filtering before crystallization begins.
The alkaline conditions used in the production of the compounds of this invention can be provided by any suitable alkalinizing agent including sodium and potassium hydroxides or alkoxides and alkylamines, but generally strong amines such as tertiary alkylamines, e.g. triethylamine or tributylamine are preferred. The amount can be varied considerably but it should be sufficient to provide, if in an aqueous system, a pH of from about 8 to 11. Generally this can be provided by an amount of, e.g., from 0.01 to 1.0%.
The alkanoic acid esters of the nitrohydroxy compounds of this invention are provided by conventional esterification reaction of the nitrohydroxy compound with an acid chloride or acid anhydride. Preferably, the acid chloride or anhydride is aliphatic of from 2 to 20 carbon atoms. The formic ester can be prepared by reaction with formic acid. The preferred esters are the acetic acid esters.
It is an embodiment of this invention to provide a method for promoting the growth of animals and improving their feed efficiency by administering to them a compound of this invention.
It is contemplated that the method of this invention will be particularly suitable for animals raised for food such as fowl, ruminants, swine and rabbits. Although all members of the fowl family--i.e. chickens, turkeys, geese, ducks, guinea, pheasant and quail--will show increased rate of growth and improved feed efficiency, the method is particularly valuable for chicken broilers and turkeys. Of the ruminants, e.g. cattle, sheep and goats, the method is particularly of value for cattle, e.g. steers.
The method of administration of a compound of this invention is to incorporate it in the feed rations intended for the animal at a concentration of about 50-150 g/ton of feed, preferably about 100 g/ton. The animals are permitted to feed at liberty throughout the growth period. There are many specialized feed rations for different species of animals. The compounds of this invention can be used with any of the known rations.
The term "feed rations" is intended to mean the food provided for the animals, and it is not intended that the invention be limited thereby. Preferably the compound is thoroughly mixed with the feed ration so that it is uniformly dispersed throughout. However, it is also contemplated that it could be sprinkled on the daily food supplies in the form of a powder or as pellets. Thus, it is not intended that the invention be limited to any particular mode of administration.
Any of the known feed rations can be used in the practice of this invention and it is not intended that the invention be limited by the formulation of the ration. Feed rations are formulated to provide the animal for which it is intended with the essential nutrients, minerals, vitamins, bulk, etc. Formulation of these rations are well within the skill of nutritionists.
The invention will be better understood with reference to the following examples. It is understood that these examples are intended for illustration only and it is not intended that the invention be limited thereby.
EXAMPLE 1
2-Formylquinoxaline-1,4-dioxide hydrate 2 g (0.01 mole) was dissolved in 100 ml of warm methanol. Ten drops of triethylamine were added with stirring and 1.3 g of methyl nitroacetate was added incrementally. The heat source was removed and the reaction mixture was allowed to cool to room temperature. The methanol was removed by evaporation and the residue was recrystallized from water, 1 g/75 ml. There was obtained methyl-α-nitro-β-hydroxy-2-quinoxalinepropionate-1,4-dioxide, m.p. 160-162. It was designated P-2229 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   46.61      3.59       13.59                                   
Found, %:   47.37      3.69       13.06                                   
______________________________________
Growth promotion and improved feed efficiency were determined as follows:
Two groups of male two-day-old broiler-type chicks were placed into Petersime starter batteries and given feed and water ad libitum for the duration of each test. Each group was subdivided into six sub-groups with ten birds in each sub-group, thus providing sixty birds per group. One group received the basal feed ration, as given in Table 1 and served as a control. The other group receives the same ration, but in addition there was included P-2229 at a concentration of 100 g/ton. The basal ration was a rye diet which alters the microflora of the gut in the bird which results in a growth depressant effect. When a growth stimulant or promotant is added to the diet, the effect on the birds performance will be more apparent than if a corn base diet was used.
The test period was thirteen days. Individual live body weights and pen feed efficiencies were taken at 2 and 14 days of age. The data are given in Table 2. Growth promotion of P-2229 is indicated by the average percentage increase in weight over that of the control group, and feed efficiency is taken as the ratio of weight of feed consumed to weight gained and the increase of this ratio over the ratio exhibited by controls is taken as the increase of feed efficiency.
______________________________________                                    
Basal Ration                                                              
______________________________________                                    
Ground rye             55.0                                               
Soybean meal 44%       29.0                                               
Fish solubles 40%      2.0                                                
Meat and bone meal 50% 5.0                                                
Dehydrated alfalfa meal                                                   
                       1.2                                                
Dried whey             1.0                                                
Fat                    4.0                                                
Dicalcium phosphate 24% ca 18.5% P                                        
                       1.0                                                
Livestock mineral 24% ca 6% P                                             
                        .75                                               
Salt                    .50                                               
Vitamin and trace mineral premix                                          
                        .50                                               
                       100 lbs                                            
Analysis                                                                  
Protein                23.3%                                              
Calcium                 1.03%                                             
Phosphorus              0.84%                                             
M.E. kg Calories/lb    1260                                               
______________________________________
The results obtained were as follows:
              TABLE 1                                                     
______________________________________                                    
               P-2229     Control                                         
______________________________________                                    
Body weight gain, av, g.                                                  
                 218.75      208.73                                       
Increase in weight, %                                                     
                 4.8         --                                           
Feed efficiency  1.48         1.49                                        
Increase in feed efficiency, %                                            
                 0.7         --                                           
______________________________________
EXAMPLE 2
The experiment of Example 1 was repeated in all essential details except that nitroethane, 1.5 g (0.02 mole) was substituted for methyl nitroacetate and it was recrystallized from ethanol. There was obtained 2-(1-hydroxy-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 206-208 with decomposition. It was designated P-2230 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   49.81      4.18       15.85                                   
Found, %:   50.82      4.17       15.13                                   
______________________________________
The results of the feeding test were as follows:
              TABLE 2                                                     
______________________________________                                    
               P-2230 P-2231    Control                                   
______________________________________                                    
Body weight gain, av, g.                                                  
                 222.37   221.54    208.77                                
Increase in weight, %                                                     
                 6.5      6.1       --                                    
Feed efficiency  1.45     1.46      1.56                                  
Increase in feed efficiency                                               
                 7.1      6.4       --                                    
______________________________________
EXAMPLE 3
The experiment of Example 2 was repeated in all essential details except that nitromethane 1.0 g (0.016 mole) was substituted for nitroethane. There was obtained 2-(1-hydroxy-2-nitroethyl)-quinoxaline-1,4-dioxide, m.p. 202°-204° C., with decomposition. It was designated P-2231 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   47.81      3.16       16.73                                   
Found, %:   47.93      3.71       16.24                                   
______________________________________
The results of the feeding test are given in Table 2.
EXAMPLE 4
The experiment of Example 2 was repeated in all essential details except that 1-nitropropane was substituted for nitroethane in an equimolar amount. There was obtained 2-(1-hydroxy-2-nitrobutyl)quinoxaline-1,4-dioxide, m.p. 197-199. It was designated P-2246 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   51.61      4.69       15.05                                   
Found, %:   52.06      4.83       14.30                                   
______________________________________
The results of the feeding test are given in Table 3.
              TABLE 3                                                     
______________________________________                                    
               P-2246 P-2265    Control                                   
______________________________________                                    
Body weight gain, av, g.                                                  
                 194.7    188.7     128.6                                 
Increase in weight, %                                                     
                 51.4     46.7      --                                    
Feed efficiency  1.54     1.59       1.82                                 
Increase in feed efficiency                                               
                 15.4     12.6      --                                    
______________________________________
EXAMPLE 5
The experiment of Example 4 was repeated in all essential details except that 2-nitropropane was substituted for 1-nitropropane. There was obtained 2-(1-hydroxy-2-methyl-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 190-192. It was designated P-2265 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   51.61      4.69       15.05                                   
Found, %:   51.91      4.75       14.67                                   
______________________________________
The results of the feeding tests are given in Table 3.
EXAMPLE 6
The experiment of Example 2 was repeated in all essential details except that 2-nitro-1-butanol was substituted for nitroethane in equimolar amounts. There was obtained 2-(1-hydroxy-2-hydroxymethyl-2-nitrobutyl)quinoxaline-1,4-dioxide, a viscous liquid. It was designated P-2280 for convenience. It causes improved growth rate and improved efficiency when tested in feed rations. P-2280 is also useful in controlling the growth of certain bacteria and fungi as shown by the following minimum inhibitory concentrations (MIC):
______________________________________                                    
                     MIC, ug/ml                                           
______________________________________                                    
Staphylococcus aureus  500-1000                                           
Streptococcus hemolyticus                                                 
                       500-1000                                           
Escherichia coli       100-500                                            
Pasteurella pseudotuberculosis                                            
                        50-100                                            
Pseudomonas aeruginosa 500-1000                                           
Shigella dysenteriae   500-1000                                           
Mycobacterium ranae     50-100                                            
Aspergillus niger      100-500                                            
Candida albicans       100-500                                            
Pencillium sp.         100-500                                            
Aspergillus fumigatus  500-1000                                           
______________________________________
EXAMPLE 7
A portion of the compound of Example 1, P-2229, was dissolved in an excess of warm acetyl chloride. The mixture was heated to boiling for about 30 minutes, then allowed to cool. The solids which separated were isolated by filtration, rinsed with ether and dried. A sample was purified by recrystallization from a mixture of dimethylsulfoxide and and methanol (1 g/5 ml/45 ml respectively). There was obtained β-acetyl-α-nitro-2-quinoxalinepropionic acid methyl ester-1,4-dioxide. It melted at 155°-158° with decomposition. It was designated P-2236 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   47.87      3.73       11.96                                   
Found, %:   47.67      3.75       11.13                                   
______________________________________
It was tested for growth promotion and ability to improve feed efficiency. The results are given in Table 4.
              TABLE 4                                                     
______________________________________                                    
               P-2236    Control                                          
______________________________________                                    
Body weight gain, av., g                                                  
                 154.92      97.33                                        
Increase in weight, %                                                     
                 59.17       --                                           
Feed efficiency  1.56         1.84                                        
Increase in feed efficiency                                               
                 15.2        --                                           
______________________________________
EXAMPLE 8
The experiment of Example 7 was repeated in all essential details except that the product of Example 2, P-2230, was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 186-190 with decomposition. It was designated P-2242 for convenience.
It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   50.81      4.26       13.68                                   
Found, %:   51.04      4.25       13.40                                   
______________________________________
The results of the growth test are given in Table 5.
              TABLE 5                                                     
______________________________________                                    
               P-2242    Control                                          
______________________________________                                    
Body weight gain, av, g                                                   
                 210.6       165.7                                        
Increase in weight, %                                                     
                 27.1        --                                           
Feed efficiency  1.48          1.57                                       
Increase in feed efficiency                                               
                 5.7         --                                           
______________________________________
EXAMPLE 9
The experiment of Example 7 was repeated in all essential details except that the product of Example 3, P-2231 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitroethyl)quinoxaline-1,4-dioxide, m.p. 201-204. It was designated P-2243 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   49.15      3.78       14.33                                   
Found, %:   48.03      3.62       12.32                                   
______________________________________
The results of the growth test are given in Table 6.
              TABLE 6                                                     
______________________________________                                    
               P-2243    Control                                          
______________________________________                                    
Body weight gain, av, g                                                   
                 240.5       144.7                                        
Increase in weight, %                                                     
                 66.2        --                                           
Feed efficiency  1.48         1.69                                        
Increase in feed efficiency                                               
                 12.4        --                                           
______________________________________
EXAMPLE 10
The experiment of Example 7 was repeated in all essential details except that P-2246 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-nitrobutyl)quinoxaline-1,4-dioxide, m.p. 156-158 with decomposition. It was designated P-2277 for convenience. It analyzed as follows:
______________________________________                                    
          C        H          N                                           
______________________________________                                    
Calc., %:   52.33      4.71       13.08                                   
Found, %:   52.24      4.75       12.93                                   
______________________________________
P-2277 improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 11
The experiment of Example 7 was repeated in all essential details except that P-2265 was substituted for P-2229. There was obtained 2-(1-acetoxy-2-methyl-2-nitropropyl)quinoxaline-1,4-dioxide, m.p. 183-185. It was designated P-2284 for convenience. P-2284 improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 12
The experiment of Example 7 is repeated in all essential details except that P-2280 is substituted for P-2229. There is obtained 2-(1-acetoxy-2-acetoxymethyl-2-nitrobutyl)quinoxaline-1,4-dioxide. The compound improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 13
The experiment of Example 2 is repeated in all essential details except that 1-nitrobutane is substituted for nitroethane in equimolar amounts. There is obtained 2-(1-hydroxy-2-nitropentyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 14
The experiment of Example 2 is repeated in all essential details except that 2-nitrobutane is substituted for nitroethane in equimolar amounts. There is obtained 2-(1-hydroxy-2-methyl-2-nitrobutyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 15
The experiments of Example 2 is repeated in all essential details except that nitrocyclohexane is substituted for nitroethane in equimolar amounts. There is obtained α-(1-nitrocyclohexyl)-2-quinoxalinemethanol-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 16
The experiment of Example 7 is repeated in all essential details except that the product of Example 13 is substituted for P-2229. There is obtained 2-(1-acetoxy-2-nitropentyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 17
The experiment of Example 7 is repeated in all essential details except that the product of Example 14 is substituted for P2229. There is obtained 2-(1-acetoxy-2-methyl-2-nitrobutyl)quinoxaline-1,4-dioxide. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.
EXAMPLE 18
The experiment of Example 7 is repeated in all essential details except that the product of Example 15 is substituted for P-2229 . There is obtained the acetic acid ester of the product of Example 15. It improves the growth rate and increases the feed efficiency of animals when included in the feed rations.

Claims (23)

We claim:
1. A method of promoting the growth rate of animals comprising administering to them daily in their feed rations a compound of the formula ##STR3## in an amount of from 50 to 150 g/ton of the feed rations, where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms, or R and R' taken together constitute an alkylene group of 5 carbon atoms.
2. Nitrohydroxyalkylquinoxaline-1,4-dioxides represented by the formula ##STR4## where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms or R and R' taken together constitute an alkylene group of five carbon atoms.
3. Compounds represented by the formula ##STR5## where R is hydrogen, lower alkyl of 1-3 carbon atoms, hydroxymethyl or acetoxymethyl and R' is hydrogen or lower alkyl of 1-2 carbon atoms or R and R' taken together constitute an alkylene group of five carbon atoms.
4. The compounds of claim 2 wherein R and R' are hydrogen.
5. The compounds of claim 2 wherein R is methyl and R' is hydrogen.
6. The compounds of claim 2 wherein R is ethyl and R' is hydrogen.
7. The compounds of claim 2 wherein R is hydroxymethyl and R' is ethyl.
8. The compounds of claim 2 wherein R is acetoxymethyl and R' is hydrogen.
9. The compounds of claim 2 wherein R and R' are methyl.
10. The compounds of claim 2 wherein R is propyl and R' is hydrogen.
11. The compounds of claim 2 wherein R is ethyl and R' is methyl.
12. The compounds of claim 2 wherein R and R' taken together constitute an alkylene group of 5 carbon atoms.
13. The compounds of claim 3 wherein R and R' taken together constitute an alkylene group of five carbon atoms.
14. A method of promoting the growth rate of animals comprising administering to them daily in their feed rations a compound of claim 2 in an amount of from 50 to 150 g/ton of the feed rations.
15. The compounds of claim 3 wherein R is propyl and R' is hydrogen.
16. The compounds of claim 3 wherein R is ethyl and R' is methyl.
17. A feed ration for animals consisting essentially of a nutritional ration containing additionally a compound of claim 2 in an amount of from 5 to 150 g/ton of the feed ration.
18. The compounds of claim 3 wherein R and R' are methyl.
19. The compounds of claim 3 wherein R and R' are hydrogen.
20. The compounds of claim 3 wherein R is methyl and R' is hydrogen.
21. The compounds of claim 3 wherein R is ethyl and R' is hydrogen.
22. The compounds of claim 3 wherein R is hydroxymethyl and R' is ethyl.
23. The compounds of claim 3 wherein R is acetoxymethyl and R' is hydrogen.
US06/040,836 1979-05-21 1979-05-21 Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof Expired - Lifetime US4303657A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/040,836 US4303657A (en) 1979-05-21 1979-05-21 Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/040,836 US4303657A (en) 1979-05-21 1979-05-21 Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof

Publications (1)

Publication Number Publication Date
US4303657A true US4303657A (en) 1981-12-01

Family

ID=21913240

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/040,836 Expired - Lifetime US4303657A (en) 1979-05-21 1979-05-21 Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof

Country Status (1)

Country Link
US (1) US4303657A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373100A (en) * 1980-06-03 1983-02-08 Egyt Gyogyszervegyeszeti Gyar Methyl-quinoxaline-1,4-dioxide derivatives
US4373101A (en) * 1980-06-03 1983-02-08 Egyt Gyogyszervegyeszeti Gyar Quinoxaline-2-yl ethenyl ketones
US4404204A (en) * 1980-07-25 1983-09-13 Patentbureau Danubia Pyridazino[4,5-b]quinoxaline-5,10-dioxide derivatives, a process for preparing same and anti-microbial compositions containing same
US4629790A (en) * 1980-08-07 1986-12-16 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4634702A (en) * 1983-11-07 1987-01-06 Daniele Gatti Quinoxalinemethanol compounds for combatting swine dysentery and as growth promoting factors, method of preparation, and compositions containing them
US4656276A (en) * 1980-08-07 1987-04-07 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4658028A (en) * 1980-08-07 1987-04-14 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4661593A (en) * 1980-08-07 1987-04-28 Angus Chemcial Company Quinoxaline adducts useful as anthelmintics
US4720548A (en) * 1980-08-07 1988-01-19 Angus Chemical Company Quinoxaline adducts useful as anthelmintics

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3344022A (en) * 1964-08-31 1967-09-26 Pfizer & Co C Method of treating chronic respiratory disease in poultry
US3453365A (en) * 1962-04-12 1969-07-01 Fisons Ltd Substituted quinoxalines as fungicides
US3560616A (en) * 1968-06-17 1971-02-02 Du Pont Process of protecting vegetation from fungi using quinoxaline foliar fungicides
DE2312730A1 (en) * 1972-03-14 1973-09-20 Ici Ltd Substd quinoxaline oxides - agricultural bactericides and fungicides
US3903281A (en) * 1972-12-15 1975-09-02 Ici Ltd Quinoxalines as fungicides and bactericides
US3926992A (en) * 1972-11-03 1975-12-16 Pfizer Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
DE2730523A1 (en) 1976-07-06 1978-01-12 Egyt Gyogyszervegyeszeti Gyar NITROALCANOL DERIVATIVES, PLANT PROTECTION PRODUCTS CONTAINING SUCH, AND PROCESS FOR THE PRODUCTION OF THE SAME

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453365A (en) * 1962-04-12 1969-07-01 Fisons Ltd Substituted quinoxalines as fungicides
US3344022A (en) * 1964-08-31 1967-09-26 Pfizer & Co C Method of treating chronic respiratory disease in poultry
US3560616A (en) * 1968-06-17 1971-02-02 Du Pont Process of protecting vegetation from fungi using quinoxaline foliar fungicides
DE2312730A1 (en) * 1972-03-14 1973-09-20 Ici Ltd Substd quinoxaline oxides - agricultural bactericides and fungicides
US3926992A (en) * 1972-11-03 1975-12-16 Pfizer Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
US3903281A (en) * 1972-12-15 1975-09-02 Ici Ltd Quinoxalines as fungicides and bactericides
DE2730523A1 (en) 1976-07-06 1978-01-12 Egyt Gyogyszervegyeszeti Gyar NITROALCANOL DERIVATIVES, PLANT PROTECTION PRODUCTS CONTAINING SUCH, AND PROCESS FOR THE PRODUCTION OF THE SAME

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Lippman, Chem. Abs., 88, 507966 (1977). *
Osumi, Chem. Abs. 81, 145628t (1972). *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373100A (en) * 1980-06-03 1983-02-08 Egyt Gyogyszervegyeszeti Gyar Methyl-quinoxaline-1,4-dioxide derivatives
US4373101A (en) * 1980-06-03 1983-02-08 Egyt Gyogyszervegyeszeti Gyar Quinoxaline-2-yl ethenyl ketones
US4404204A (en) * 1980-07-25 1983-09-13 Patentbureau Danubia Pyridazino[4,5-b]quinoxaline-5,10-dioxide derivatives, a process for preparing same and anti-microbial compositions containing same
US4629790A (en) * 1980-08-07 1986-12-16 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4656276A (en) * 1980-08-07 1987-04-07 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4658028A (en) * 1980-08-07 1987-04-14 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4661593A (en) * 1980-08-07 1987-04-28 Angus Chemcial Company Quinoxaline adducts useful as anthelmintics
US4720548A (en) * 1980-08-07 1988-01-19 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4634702A (en) * 1983-11-07 1987-01-06 Daniele Gatti Quinoxalinemethanol compounds for combatting swine dysentery and as growth promoting factors, method of preparation, and compositions containing them

Similar Documents

Publication Publication Date Title
DE1620114B2 (en) SHIP'S BASES OF 2-FORMYLCHINOXALIN-1,4-DIOXIDES
US4303657A (en) Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof
US4711897A (en) Animal feed methods and compositions using cysteamine
US4373101A (en) Quinoxaline-2-yl ethenyl ketones
US4221791A (en) Substituted quinoxaline dioxides
US3926992A (en) Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
US3974277A (en) 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents
US4241061A (en) Oxazolidinyl-quinoxalines and use as growth promoters
US4454137A (en) Feed compositions containing copper salts of 2-hydroxypyridine-N-oxides
US4128642A (en) Method of promoting growth and improving feed efficiency of animals
US3728345A (en) Preparation of quinoxaline-2-carboxamide derivatives
SU668572A3 (en) Animal growth stimulator
US3973021A (en) 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide
US3970648A (en) 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines
DE3234995A1 (en) Growth-promoting phenylethylamine derivatives
US4505917A (en) Feed compositions containing a (1-oxo-2-pyridyl) disulfide
US3850987A (en) Compounds useful as feed supplements
US4311710A (en) Anticoccidial formulation and method
US4463009A (en) Dialkyl 1-(2-pyridinylthio)-1,2-hydrazinedicarboxylate, N-oxides and their use as animal growth stimulants
US3763162A (en) Transesterification of quinoxaline-2-carboxylic acid esters
US3644360A (en) 3-substituted methylquinoxaline-2-carboxamide-1 4-dioxides
US3907994A (en) Substituted alkyl esters quinoxaline-di-N-oxide-2-carboxylic acid as growth promoting agents
US2929713A (en) Preparation of coumestrol esters and use thereof
US3818007A (en) Hydroxyalkyl esters of quinoxaline-di-n-oxide-2-carboxylic acid
US4680304A (en) Feed compositions containing 2-(α-pyridyl)-Δ2 -heterocyclic compounds

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE